Independent report

COVID-19 vaccination of children aged 6 months to 4 years: JCVI advice, 9 December 2022 (updated 26 April 2023)

Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination for children aged 6 months to 4 years.

• From: Department of Health and Social Care
• Published: 6 April 2023
• Last updated: 3 May 2023 — See all updates

Documents

COVID-19 vaccination of children aged 6 months to 4 years: JCVI advice, 9 December 2022 (updated 26 April 2023)

HTML

Details

JCVI advises children aged 6 months to 4 years in a clinical risk group should be offered 2 3-microgram doses of the Pfizer-BioNTech COVID-19 vaccine.

Further advice regarding a potential third 3-microgram dose of the Pfizer-BioNTech COVID-19 vaccine will be issued in due course.

JCVI does not currently advise COVID-19 vaccination of children aged 6 months to 4 years who are not in a clinical risk group.

JCVI has previously offered advice regarding the vaccination of children aged 5 to 11.

Published 6 April 2023

Last updated 3 May 2023 + show all updates

1. 3 May 2023

   Updated to remove the minimum interval of 4 weeks between any vaccine dose and recent SARS-COV-2 infection from the 'Advice' section. This advice was registered in the Green Book on 26 April 2023.

2. 6 April 2023

   First published.